Search for other papers by Stavroula A Paschou in
Google Scholar
PubMed
Search for other papers by Nektaria Papadopoulou-Marketou in
Google Scholar
PubMed
Search for other papers by George P Chrousos in
Google Scholar
PubMed
Search for other papers by Christina Kanaka-Gantenbein in
Google Scholar
PubMed
Introduction Type 1 diabetes mellitus (T1DM) represents only around 10% of the diabetes cases worldwide, but occurs with increasing incidence much earlier in life. T1DM results from the autoimmune destruction of β cells of the endocrine
Search for other papers by Rama Lakshman in
Google Scholar
PubMed
Cambridge University Hospitals NHS Foundation Trust, Wolfson Diabetes and Endocrine Clinic, Cambridge, UK
Search for other papers by Charlotte Boughton in
Google Scholar
PubMed
Search for other papers by Roman Hovorka in
Google Scholar
PubMed
Introduction Over nine million people worldwide live with type 1 diabetes (T1D) ( 1 ). In this condition, immune-mediated destruction of pancreatic beta-cells leads to insulin deficiency and resultant hyperglycaemia. The management of T1D
Search for other papers by Louise Færch in
Google Scholar
PubMed
Department of Cardiology, Department of Growth and Reproduction, Faculty of Health Sciences, Nephrology and Endocrinology H, Hillerød University Hospital, Dyrehavevej 29, DK-3400 Hillerød, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
Search for other papers by Ulrik Pedersen-Bjergaard in
Google Scholar
PubMed
Department of Cardiology, Department of Growth and Reproduction, Faculty of Health Sciences, Nephrology and Endocrinology H, Hillerød University Hospital, Dyrehavevej 29, DK-3400 Hillerød, Denmark
Search for other papers by Birger Thorsteinsson in
Google Scholar
PubMed
Introduction GH is part of the second-line counter-regulatory response to hypoglycemia and acts by promoting gluconeogenesis. In long-standing type 1 diabetes with counter-regulatory failure in terms of diminished glucagon and adrenaline responses
Surgery Research Unit, Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland
Search for other papers by Olli Helminen in
Google Scholar
PubMed
Search for other papers by Tytti Pokka in
Google Scholar
PubMed
Search for other papers by Susanna Aspholm in
Google Scholar
PubMed
Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland
Search for other papers by Jorma Ilonen in
Google Scholar
PubMed
Search for other papers by Olli G Simell in
Google Scholar
PubMed
Pediatric Research Center, New Children’s Hospital, Helsinki University Hospital, Helsinki, Finland
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Search for other papers by Mikael Knip in
Google Scholar
PubMed
Search for other papers by Riitta Veijola in
Google Scholar
PubMed
Introduction Type 1 diabetes is one of the most common chronic diseases in childhood. The incidence rate has been rising throughout the Western world ( 1 ). The incidence is highest in Finland, in 2006 as high as 64.3 per 100,000 children
Search for other papers by W Liu in
Google Scholar
PubMed
Search for other papers by Y Wang in
Google Scholar
PubMed
Search for other papers by X Han in
Google Scholar
PubMed
Search for other papers by X Cai in
Google Scholar
PubMed
Search for other papers by Y Zhu in
Google Scholar
PubMed
Search for other papers by M Zhang in
Google Scholar
PubMed
Search for other papers by S Gong in
Google Scholar
PubMed
Search for other papers by J Li in
Google Scholar
PubMed
Search for other papers by L Ji in
Google Scholar
PubMed
Introduction Chronic complications cause the largest proportion of deaths and increase in prevalence with the duration of the disease in long-standing type 1 diabetes (T1DM). ( 1 ) Indeed, the duration of diabetes and severity of hyperglycemia
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China
Search for other papers by Lili Liu in
Google Scholar
PubMed
Search for other papers by Zhuo Shao in
Google Scholar
PubMed
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China
Search for other papers by Ying Xia in
Google Scholar
PubMed
Search for other papers by Jiabi Qin in
Google Scholar
PubMed
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China
Search for other papers by Yang Xiao in
Google Scholar
PubMed
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China
Search for other papers by Zhiguang Zhou in
Google Scholar
PubMed
Search for other papers by Zubing Mei in
Google Scholar
PubMed
Introduction Type 1 diabetes mellitus (T1DM), which is caused by the selective destruction of the insulin-producing β cells located in the pancreatic islets of Langerhans, is one of the most common and debilitating autoimmune diseases ( 1
Search for other papers by Annalisa Blasetti in
Google Scholar
PubMed
Search for other papers by Valeria Castorani in
Google Scholar
PubMed
Search for other papers by Nella Polidori in
Google Scholar
PubMed
Search for other papers by Ilaria Mascioli in
Google Scholar
PubMed
Search for other papers by Francesco Chiarelli in
Google Scholar
PubMed
Search for other papers by Cosimo Giannini in
Google Scholar
PubMed
Introduction Type 1 diabetes (T1D) and other chronic diseases are well recognized to adversely affect linear growth in childhood. Indeed, early studies have shown that suboptimal glycemic control and longer disease duration can impair
Department of Endocrinology, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway
Search for other papers by Unni Syversen in
Google Scholar
PubMed
Medical Clinic, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway
Search for other papers by Mats Peder Mosti in
Google Scholar
PubMed
Search for other papers by Ida Maria Mynarek in
Google Scholar
PubMed
Search for other papers by Trude Seselie Jahr Vedal in
Google Scholar
PubMed
Department of Gastroenterology, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway
Search for other papers by Kristin Aasarød in
Google Scholar
PubMed
Search for other papers by Trude Basso in
Google Scholar
PubMed
Search for other papers by Janne E Reseland in
Google Scholar
PubMed
Search for other papers by Per Medbøe Thorsby in
Google Scholar
PubMed
K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Trondheim, Norway
Search for other papers by Bjorn O Asvold in
Google Scholar
PubMed
Search for other papers by Erik Fink Eriksen in
Google Scholar
PubMed
Medical Clinic, Trondheim University Hospital (St Olavs Hospital), Trondheim, Norway
Search for other papers by Astrid Kamilla Stunes in
Google Scholar
PubMed
men with type 1 diabetes and age-matched control subjects. Variables Type 1 diabetes patients ( n = 33) Control subjects ( n = 28) P -value Age (years) 42.7 ± 12.1 41.8 ± 12.0 0.744 Age at diagnosis (years) 19
Search for other papers by Wei Liu in
Google Scholar
PubMed
Search for other papers by Yunke Ma in
Google Scholar
PubMed
Search for other papers by Xiaoling Cai in
Google Scholar
PubMed
Search for other papers by Yu Zhu in
Google Scholar
PubMed
Search for other papers by Mingxia Zhang in
Google Scholar
PubMed
Search for other papers by Juan Li in
Google Scholar
PubMed
Search for other papers by Jing Chen in
Google Scholar
PubMed
Search for other papers by Dawei Shi in
Google Scholar
PubMed
Search for other papers by Linong Ji in
Google Scholar
PubMed
Introduction Measurement of serum C-peptide is important in clinical practice since differences in intrinsic insulin secretion are fundamental to diabetes classification and treatment strategy ( 1 ). In clinically diagnosed type 1 diabetes
Department of Research and Development, Region Kronoberg, Växjö, Sweden
Region Kronoberg, Primary Care, Växjö, Sweden
Search for other papers by Eva Olga Melin in
Google Scholar
PubMed
Search for other papers by Jonatan Dereke in
Google Scholar
PubMed
Department of Research and Development, Region Kronoberg, Växjö, Sweden
Department of Internal Medicine, Endocrinology and Diabetes, Central Hospital, Växjö, Sweden
Search for other papers by Maria Thunander in
Google Scholar
PubMed
Search for other papers by Magnus Hillman in
Google Scholar
PubMed
Introduction Depression is associated with type 1 diabetes (T1D), Alzheimer’s disease, increased coronary heart disease and both coronary and all-cause mortality ( 1 , 2 , 3 ). T1D has a serious impact on mental health, indicated by the more